Fragasso Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $229K | Hold |
2,760
| – | – | 0.02% | 261 |
|
2025
Q1 | $224K | Buy |
2,760
+1
| +0% | +$81 | 0.02% | 245 |
|
2024
Q4 | $249K | Hold |
2,759
| – | – | 0.02% | 233 |
|
2024
Q3 | $273K | Sell |
2,759
-41
| -1% | -$4.05K | 0.02% | 219 |
|
2024
Q2 | $260K | Buy |
2,800
+2
| +0.1% | +$185 | 0.02% | 228 |
|
2024
Q1 | $266K | Hold |
2,798
| – | – | 0.02% | 222 |
|
2023
Q4 | $250K | Sell |
2,798
-284
| -9% | -$25.4K | 0.02% | 222 |
|
2023
Q3 | $225K | Hold |
3,082
| – | – | 0.02% | 211 |
|
2023
Q2 | $256K | Buy |
3,082
+41
| +1% | +$3.41K | 0.03% | 205 |
|
2023
Q1 | $232K | Hold |
3,041
| – | – | 0.03% | 198 |
|
2022
Q4 | $252K | Buy |
+3,041
| New | +$252K | 0.03% | 182 |
|